SEC Form 5 · accession 0000914190-17-000051
REGENERX BIOPHARMACEUTICALS INC · RGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J J Finkelstein
Officer — President and CEO · Director
Period of report
Dec 31, 2016
Accepted (ET)
Feb 14, 2017 · 5:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000707511
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 1, 2016 | W | 210,550 | $0.00 | A | 1,488,188 | D | |
| Common Stock | Dec 30, 2016 | G | 100,000 | $0.00 | D | 1,388,188 | D |
Table II — derivative securities
No Table II lines on this filing.